A team of researchers has discovered that a protein called cypin plays a powerful role in helping brain cells connect and ...

Alzheimer’s disease continues to rise as one of the most pressing health challenges facing aging populations today. It ...

Kevin Smith, a resident of Clifton Park, is experiencing the benefits of a recently approved Alzheimer's drug, Leqembi, as he ...

What exactly is Alzheimer’s disease, and how common is it? A: Alzheimer’s disease is a neurodegenerative disease that causes dementia. It is caused in part by the accumulation of abnormally folded ...

The study, published March 6 in Nature Medicine, shows that the brain’s immune cells, called microglia, play a more powerful ...

June is Alzheimer's and Brain Awareness Month. With an estimated 55 million people living with Alzheimer's Disease and other ...

Lilly's Kisunla gets FDA approval for a new dosing schedule that significantly lowers ARIA-E risk while maintaining amyloid ...

A once-a-day pill called blarcamesine may slow memory loss and preserve independence—without the scary side effects or ...

Helicobacter pylori, best known for causing stomach ulcers, was shown to block the build-up of both amyloid-beta and tau in our study.

Two breakthrough Alzheimer's drugs have been deemed far too expensive, for too little benefit, to be offered on the NHS. The medicines are the first to slow the disease, which may give people extra ...

David Olsen, Director of State Affairs for the Alzheimer’s Association, joins Lisa Dent to talk about Illinois becoming the first state to require insurance to provide coverage for ...